Hemocor HPH HPH JuniorRecalls & reported problems
Medivators Inc. · High Performance Hemoconcentrator - HPH Junior · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00677964000867), received between Sep 19, 2018 and Aug 5, 2021 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Detachment of Device or Device Component1
- Leak/Splash1
Patient problems
- Blood Loss1
- No Clinical Signs, Symptoms or Conditions1
- No Consequences Or Impact To Patient1
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 5, 2021Leak/Splash; Leak/Splash
A MEDIVATORS DISTRIBUTOR OF BLOOD FILTERS, REPORTED THAT A FILTER LEAK OCCURRED DURING USE WHICH RESULTED IN APPROXIMATELY 20ML OF PATIENT BLOOD LOSS. AS THE PATIENT WAS PEDIATRIC, AN ERYTHROCYTE TRANSFUSION WAS PERFORMED. NO FURTHER MEDICAL INTERVENTION OR ADVERSE EFFECT WAS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12284836 ↗InjurySep 19, 2018Detachment of Device or Device Component; Detachment of Device or Device Component
(B)(4), DISTRIBUTOR OF HEMOCOR HEMOCONCENTRATORS, REPORTED ON BEHALF OF A USER FACILITY THAT WHILE USING A HPH JUNIOR HEMOCONCENTRATOR DURING A BYPASS PROCEDURE, A PEDIATRIC PATIENT LOST LESS THAN 10 ML OF BLOOD. THE BLOOD LOSS WAS REPORTED TO BE DUE TO A LEAK OUT OF THE HEADER CAP. THERE WERE NO ADVERSE EFFECTS AS A RESULT OF THE REPORTED COMPLAINT.
Patient problems: Blood Loss; No Consequences Or Impact To Patient; No Known Impact Or Consequence To Patient
MAUDE report 7891581 ↗
Other Dialyzer, High Permeability With Or Without Sealed Dialysate System devices
- Optiflux® 0500318EFresenius Medical Care Holdings, Inc. · Dialyzer, high permeability with or without sealed dialysate system1 recall6 deaths2,849 reports
- 2008® Series Hemodialysis Machines 190713Fresenius Usa, Inc. · Dialyzer, high permeability with or without sealed dialysate system3 recalls37 deaths893 reports
- 2008T BlueStar Hemodialysis Machine 191126Fresenius Medical Care Holdings, Inc. · Dialyzer, high permeability with or without sealed dialysate system5 recalls10 deaths441 reports
- 2008® Series Hemodialysis Machines 190766Fresenius Usa, Inc. · Dialyzer, high permeability with or without sealed dialysate system4 recalls15 deaths370 reports
- 2008T BlueStar Hemodialysis Machine 191130Fresenius Medical Care Holdings, Inc. · Dialyzer, high permeability with or without sealed dialysate system4 recalls7 deaths272 reports
- 2008® Series Hemodialysis Machines 190610Fresenius Usa, Inc. · Dialyzer, high permeability with or without sealed dialysate system1 recall15 deaths335 reports
- Optiflux® 0500320EFresenius Medical Care Holdings, Inc. · Dialyzer, high permeability with or without sealed dialysate system2 recalls242 reports
- REVACLEAR 300Gambro Renal Products, Inc. · Dialyzer, high permeability with or without sealed dialysate system3 recalls125 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page